Interactive discussion: applying Lp(a)-informed risk stratification and treatment intensification in practice

28 August 2026 (10:35 - 10:43)

Organised by:

Video

Sign in to view the resources

Slides

About the speakers

Professor Florian Kronenberg

Medical University of Innsbruck, Innsbruck (Austria)

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkiye)

Professor Klaus G Parhofer

Ludwig Maximilians University, Munich (Germany)

4 More presentations in this session

Presentation thumbnail

Introduction and opening poll

Professor F. Kronenberg (Innsbruck, AT)

Presentation thumbnail

Beyond standard risk factors - identifying hidden ASCVD risk and recognising the role of Lp(a)

Professor L. Tokgozoglu (Ankara, TR)

Presentation thumbnail

From risk stratification to action — intensifying prevention through evidence-based and patient-centered ASCVD management

Professor K. Parhofer (Munich, DE)

Presentation thumbnail

Summary & closure

Professor F. Kronenberg (Innsbruck, AT)

Access the full session

Session thumbnail

Hidden risk, clear guidance: strategies for excellence in atherosclerotic cardiovascular disease (ASCVD) prevention

The Event

Event poster

ESC Congress 2026

28 August 2026 10:35 CET

You may be interested in

Congress Presentation

Everything you wanted to know about lipoprotein(a) - discussion

30 August 2026

Congress Presentation

EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .

29 August 2022

Congress Presentation

Case 3: a 50-year-old man, LDL well controlled, but strong family history and markedly elevated Lp(a).

25 April 2026

Congress Presentation

Conclusion and Q&A

31 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources